Management
Andy Badolato, Chairman, Chief Executive Officer
Mr. Badolato has 22 yrs experience in Venture Capital, Technology Transfer, M&A transactions, Mezzanine and Public equity financings; and the creation, business development, and oversight of public and private companies.
Mr. Badolato has been a co- founder and or early stage investor in 23 plus companies that have raised over one billion in private equity and obtained an aggregate high market capitalization of over 29 billion dollars. He was the founder, President and Director of MILCOM Technologies successfully licensing over 1.6 billion dollars of research and development from Lockheed Martin. MILCOM, a leader in commercializing technologies that originate in the defense industry, has launched thirteen companies that have obtained over 600 million dollars in venture capital.
Mr. Badolato was VP Corporate finance of St James, the founder and intial seed round investors of Inktomi, a company that obtained a 20 billion dollar public market valuation. Mr. Badolato was the founding President and Director of SinoFresh HealthCare, Inc, a developer and marketer of innovative therapies to treat inflammatory and infectious diseases of the upper respiratory system. Mr. Badolato successfully launched the Company's lead product, SinoFresh(TM) Nasal, Oral & Sinus Care, to a national distribution contract making it available in over 20,000 retail outlets nationwide.
Mr. Badolato is a cofounder of Industrial Biotechnology Corporation. He also is Managing Director of White Knights & Vultures LLC., a Venture Capital Hedge Fund. Mr. Badolato graduated from St. Thomas of Villanova University in Miami, Florida, with a Bachelors of Arts in Business.
David Otto, Director
David M. Otto is a Seattle-based attorney and President of the Otto Law Group. Mr. Otto's practice focuses on corporate finance, securities, mergers and acquistions and corporate law and goverance. Mr. Otto has authored "Venture Capital Financing", "Taking Your Company Public" and "Structuring the Deal: Fundamental Issues to Consider in Connection with Buying or Selling a Business" and lectured to businessmen, accountants, lawyers, and gradutate students at the University of Washington Business School on venture capital financing, going public and mergers and acquisitions. He is currently a member of the Board of Directors of many public and private companies and is also a member of the American Bar Association Committee on the Federal Regulation of Securities, Subcommittee on the 1933 Act and Chairman of the Legislation Subcommittee of the ABA's Venture Capital and Private Equity Committee. Mr. Otto is admited to practice law in New York and Washington. Mr. Otto graduated from Harvard University in 1981, where he earned his A.B. in Government and was the reipient of the Harvard-Shrewbuty Fellowship, and Fordham University School of Law in 1987 where he earned his Juris Doctorate and served as a Commentary Editor on the Fordham International Law Journal.
Tom Hentschell, Vice President Operations
Mr. Hentschell has 24 years of operational, sales and marketing experience and business development. He has has worked at companies such as Infinium Labs and Iprint Technologies, and Xerox Corporation where he was instrumental in launching the Channels division and securing contracts with Merck, Baxter, United Healthcare, and Blue Cross & Blue Shield Assoc. Mr. Hentschell graduated at Loyola of New Orleans, Bachelors of Arts & Business.
Ron Doran, Director and Vice President Sales
Mr. Doran has extensive sales and marketing experience in Asian market product development, distribution, outsourcing and manufacturing channels. Mr. Doran has also served as a merchant banker and has overseen development, financing, and strategic relationships for various healthcare and technology companies including Uniphyd Corporation, Milcom, and Terranex. Mr. Doran is a cofounder of Industrial Biotechnology.
Craig McClure, Vice President Investor and Public Relations
Mr. McClure has 20 years experience in investment management, retail brokerage, and venture capital. He has worked at Wachovia Securities, Aegon NV Brokerage, and LaSalle St. Securities as a Registered Representative and Branch Manager. He has experience in both public and private capital transactions and has worked with a vast number of clients and market transactions. Mr. McClure attended State University of New York at Potsdam.
Harvey Hendler, Strategic Planning
Mr. Hendler specializes in strategic business planning and operations. His corporate clients include: Dow, Ciba, GlaxoSmithKline, InfoMedics, Monsanto, Pfizer, Roche, Millennium chemicals, FMC Corporation and International Paper. Mr. Hendler has a Master of Science Degree in Management from the New Jersey Institute of Technology.
Gurinder Shahi, MD, PhD, MPH. Chief Technologist & Chairman Scientific Advisory Board
Dr. Shahi is a physician with training in molecular biochemistry and in international policy and management. He is a leading expert on technology innovation and change management in healthcare and the life sciences, and has a particular interest in the commercialization of promising new bio-technologies to address environmental, energy, health and socio-economic development concerns. He has played a key role in the development of several major international initiatives including the International Vaccine Institute (now based in Seoul, Korea), the Asia-Pacific International Molecular Biology Network and the Global BioBusiness Initiative, and has served as advisor and consultant to leading international organizations, governments, corporations and foundations around the world. He has also been actively involved in establishing and providing strategic and management input to a range of promising technology enterprises including Lynk Biotechnologies (Asia) and Industrial Biotechnology Corporation (US/Europe/Asia/Latin America). Dr. Shahi has authored over 60 articles, journal papers and conference presentations and served as lead editor for International Perspectives on Environment, Development and Health: Toward a Sustainable World (GS Shahi, BS Levy, A Binger, T Kjellstrom and RS Lawrence, Springer Publishing Company, New York, 1997). His books include BioBusiness in Asia: How Asia Can Capitalize on the Life Science Revolution (Pearson Prentice Hall, 2004) and Financing Technology Innovation (with Joseph Greco, GBI Books, 2007). Dr Shahi holds an MD and PhD (in molecular biochemistry) from the National University of Singapore and an MPH (International Policy and Management) from Harvard University.He has been a Warren Weaver Fellow (Global Environment and Health Sciences) at The Rockefeller Foundation.
Gary Howell, Ph.D., Advisory Board- Former Vice President Business Development
Dr. Howell has overseen and led diverse businesses within consumer products, biotechnology, R&D, and technology transfer. He has held leadership roles in organizations ranging from start-ups to Fortune 500 corporations with responsibilities in technology assessment, strategy development, market research and business development. Dr. Howell served as Director of the Cincinnati Center for Clinical Research and Head of Venture Development at Cincinnati Children's Hospital Medical Center; interim CEO of Genomatix (now Intrexon), a biotechnology company; and at Procter & Gamble Analytical Chemistry and Technology/Product Development departments. Dr. Howell holds several degrees, including: a Ph.D. and M.S. in Chemistry from Cornell University and a B.S. in Chemistry, cum laude, from the StateUniversity of New York College at Cortland. In addition, his association memberships have included: the Association of University Technology Managers, American Chemical Society, American Association for the Advancement of Science and Sigma Xi.
Larry Drumm- Advisory Board
Mr. Drumm has extensive experience in the industrial biotechnology industry. He has served as a senior executive at many companies including; Bio-Technical Resources (A division of Arkion Life Sciences LLC) as Vice-President, Business Development, at DCV (a group of DuPont/ConAgra companies) now called Arkion, as Development Manager of Biochemical Products, Director of Marketing and Strategic Planning and Director of Marketing, BTR Separations. At Genencor International, formerly Eastman Kodak Company, Mr. Drumm served as Director of Business Development, Manager of Commercial Development and Manager of Marketing Planning. At Eastman Chemical Products, Inc. Mr. Drumm served as Product Supervisor and Marketing Representative. Mr. Drumm holds an M.B.A. from University of Hartford and a B.S. in Chemical Engineering, University of Cincinnati. Mr. Drumm has also been Commercial Development and Marketing Association two time President which is the Business Development Community for the Chemical Industry. He is a member of the American Chemical Society and in the Biotechnology Industry Organization, (BIO) has also served as the organizer of the Chief Technical Officer Summit on Biotechnology in the Chemical Industry. as well as a Founding Board Member of BIO's Industrial and Environmental Section. He is a member of the Society for Industrial Microbiology. Mr Drumm is also a member of the Societal Impact Operating Committee of the AIChE and Founding Member of the Society for Biological Engineering
Doug Forde, Audit Committee and Advisory Board Member
Mr. Forde is a career business professional with a background in finance, taxation capital markets, and mergers and acquisitions. He has held senior level positions in private and public companies, including KPMG Peat Marwick, McGraw-Hill, and Xerox Corporation, and CEO positions with three businesses he helped to transition from the private sector to the public sector. Mr. Forde’s list of accomplishments include tax planning for US companies abroad, tax strategies for foreign companies in the United States, and a role in more than 100 mergers and acquisitions, leveraged buyouts, and corporate divestitures. Mr. Forde is a published author with hundreds of articles and research white papers regarding taxation, auditing and corporate finance industries. He has lectured at many universities and colleges and holds the title of Visiting Professor at many leafing educational institutions. Mr. Forde has served on the board of directors of public and private companies including Virgin Islands Flight Schools, Eastern Caribbean Airways, Inc., International Banks, Hospitals and Health Care Companies, and Universities. Mr. Forde is a graduate of the University of the Virgin Islands, the University of Illinois Urbana-Champaign , and Baruch College of the City University of New York, and holds degrees in accounting, finance, and taxation.
